JPS55167265A - Recognin m and l and their chemoreciprocals - Google Patents

Recognin m and l and their chemoreciprocals

Info

Publication number
JPS55167265A
JPS55167265A JP3017780A JP3017780A JPS55167265A JP S55167265 A JPS55167265 A JP S55167265A JP 3017780 A JP3017780 A JP 3017780A JP 3017780 A JP3017780 A JP 3017780A JP S55167265 A JPS55167265 A JP S55167265A
Authority
JP
Japan
Prior art keywords
recognin
recognins
termed
approximately
tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3017780A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6362517B2 (https=
Inventor
Bogoshi Samiyueru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS55167265A publication Critical patent/JPS55167265A/ja
Publication of JPS6362517B2 publication Critical patent/JPS6362517B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/473—Recognins, e.g. malignin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
JP3017780A 1979-03-09 1980-03-10 Recognin m and l and their chemoreciprocals Granted JPS55167265A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1907879A 1979-03-09 1979-03-09

Publications (2)

Publication Number Publication Date
JPS55167265A true JPS55167265A (en) 1980-12-26
JPS6362517B2 JPS6362517B2 (https=) 1988-12-02

Family

ID=21791299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3017780A Granted JPS55167265A (en) 1979-03-09 1980-03-10 Recognin m and l and their chemoreciprocals

Country Status (4)

Country Link
EP (1) EP0015755B1 (https=)
JP (1) JPS55167265A (https=)
AT (1) ATE8897T1 (https=)
DE (1) DE3068844D1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008014746A (ja) * 2006-07-05 2008-01-24 Sumika Chemical Analysis Service Ltd 細胞に取り込まれた被験化合物の定量方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
EP0221748A3 (en) * 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
EP0681480B1 (en) * 1993-03-16 2004-01-07 Samuel Dr. Bogoch Recognin vaccines

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4830445A (https=) * 1971-08-24 1973-04-21
JPS50103037A (https=) * 1974-01-25 1975-08-14
JPS52104649A (en) * 1976-02-28 1977-09-02 Toyoda Gosei Kk Gear with plastic shaft

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
GB1533464A (en) * 1975-02-18 1978-11-22 Bogoch S Cancer diagnostic agents
GB1524221A (en) * 1975-08-01 1978-09-06 Bogoch S Cancer diagnostic agents
GB1532803A (en) * 1975-10-15 1978-11-22 Bogoch S Cancer diagnostic agents
DE2546670A1 (de) * 1975-10-17 1977-04-21 Samuel Bogoch Recognine
DE2824917A1 (de) * 1977-07-13 1979-02-01 Corning Glass Works Biologisch aktive konjugate
DE2967534D1 (en) * 1978-07-07 1985-11-28 Bogoch Samuel Product for detecting the presence of cancerous or malignant tumor cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4830445A (https=) * 1971-08-24 1973-04-21
JPS50103037A (https=) * 1974-01-25 1975-08-14
JPS52104649A (en) * 1976-02-28 1977-09-02 Toyoda Gosei Kk Gear with plastic shaft

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008014746A (ja) * 2006-07-05 2008-01-24 Sumika Chemical Analysis Service Ltd 細胞に取り込まれた被験化合物の定量方法

Also Published As

Publication number Publication date
JPS6362517B2 (https=) 1988-12-02
EP0015755B1 (en) 1984-08-08
EP0015755A2 (en) 1980-09-17
EP0015755A3 (en) 1980-12-10
ATE8897T1 (de) 1984-08-15
DE3068844D1 (en) 1984-09-13

Similar Documents

Publication Publication Date Title
Blakeslee et al. Immunofluorescence using dichlorotriazinylaminofluorescein (DTAF) I. Preparation and fractionation of labelled IgG
EP0221748A3 (en) A process for the production of human antibodies
AU594488B2 (en) Agents for the treatment of arthroses
JPS56100638A (en) Cation exchange resion and its preparation and its use
FR2440011A1 (fr) Lentille ophtalmique, en particulier pour fort myope
IE34676B1 (en) Benzimidazo (2,1-b) quinazolin derivatives as immuno suppressants
JPS55167265A (en) Recognin m and l and their chemoreciprocals
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
ES8206855A1 (es) Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.
EP0877938A1 (de) Verfahren zur markierung von biomolekülen mit meerrettichperoxidase
JPS5483989A (en) Preparation of hydrophilic polymer
GB1524221A (en) Cancer diagnostic agents
IE781891L (en) Fibrous milk protein product.
FR2432510B1 (https=)
JPS6463374A (en) Human monoclonal antibody, antibody-forming cell, antibody-forming hybridoma and production of antibody
EG20913A (en) Method for the preparation of cation exchange membranes doped with insoluble metal salts
EP0141630A3 (en) Tough, transparent lead ionomers with greater than 100% neutralization
SU493710A1 (ru) Способ количественного определени гексозаминов
JPS5382666A (en) Preparation for hydrogel having high water absorbing property
JPS53142594A (en) Immobilization of enzyme or microbial cells
JPS5429393A (en) Preparation of modified polyester
JPS5291898A (en) Water-insoluble tannin preparation
JPS5611793A (en) Fixed enzyme composition and its preparation
Iida et al. Adherence of Pseudomonas aeruginosa to SIRG Cells-Preliminary Report.
GB1288789A (en) Improved bismuth preparations